Inventors:
Michael McMains - Indianapolis IN, US
Caren Geppert - Indianapolis IN, US
Missy Siegel - Idianapolis IN, US
International Classification:
A61K031/198, A61K033/06
Abstract:
A method of preventing or treating hypomagnesemia in pediatric patients and patients with G-tubes or NG-tubes comprising the step of administering a pharmaceutical composition comprised of a magnesium salt, magnesium-L-aspartate hydrochloride, in a water-soluble powder concentrate. When dissolved in water, the pharmaceutical composition provides a method for preventing or treating hypomagnesemia in such patients without compromising the absorption or efficacy of the pharmaceutical composition.